Symbols / ODTC $150000.00 +7.14% Odonate, Inc.
ODTC Chart
About
Odonate, Inc., has no significant operations. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
Fundamentals
Scroll to Statements| Market Cap | 53.40M | Enterprise Value | 5.77T | Income | -102.07M | Sales | — | Book/sh | 148380.45 | Cash/sh | 2.47 |
| Dividend Yield | — | Payout | 0.00% | Employees | 137 | IPO | — | P/E | 7.29 | Forward P/E | -1875000.00 |
| PEG | — | P/S | — | P/B | 1.01 | P/C | — | EV/EBITDA | -72003.55 | EV/Sales | — |
| Quick Ratio | 3.14 | Current Ratio | 3.29 | Debt/Eq | 6.79 | LT Debt/Eq | — | EPS (ttm) | 20580.00 | EPS next Y | -0.08 |
| EPS Growth | — | Revenue Growth | — | Earnings | 2021-07-27 | ROA | -33.09% | ROE | -86.14% | ROIC | — |
| Gross Margin | 0.00% | Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 356.00 | Shs Float | 35.14M | Short Float | 2.31% |
| Short Ratio | 0.59 | Short Interest | — | 52W High | 150000.00 | 52W Low | 50000.00 | Beta | 0.46 | Avg Volume | 0.00 |
| Volume | 1.00 | Target Price | — | Recom | None | Prev Close | $140000.00 | Price | $150000.00 | Change | 7.14% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$150000.00
Latest analyst target
3. DCF / Fair value
$-2226273.98
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$150000.00
Low
—
High
—
Mean
—
- Odonate, Inc. (ODTC) stock price, news, quote and history - Yahoo Finance Singapore hu, 17 Aug 2023 07
- DWC forks out P762M for subsidiaries - Inquirer.net Wed, 18 Dec 2024 08
- Discovery World to expand resorts in El Nido, Siargao, Davao with P762-million investment - Manila Bulletin ue, 17 Dec 2024 08
- Discovery World infusing P577 million fresh capital into units - Philstar.com Wed, 18 Dec 2024 08
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
0.82
-79.15%
|
3.92
-94.28%
|
68.48
|
| Research And Development |
|
—
|
0.00
-100.00%
|
47.77
|
| Selling General And Administration |
|
0.82
-79.15%
|
3.92
-81.08%
|
20.72
|
| General And Administrative Expense |
|
0.82
-79.15%
|
3.92
-81.08%
|
20.72
|
| Other Gand A |
|
0.82
-79.15%
|
3.92
-81.08%
|
20.72
|
| Total Expenses |
|
0.82
-79.15%
|
3.92
-94.28%
|
68.48
|
| Operating Income |
|
-0.82
+79.15%
|
-3.92
+94.28%
|
-68.48
|
| Total Operating Income As Reported |
|
-0.82
+79.15%
|
-3.92
+94.28%
|
-68.48
|
| EBITDA |
|
-0.80
+79.10%
|
-3.81
+94.40%
|
-68.01
|
| Normalized EBITDA |
|
-0.80
+79.10%
|
-3.81
+94.40%
|
-68.01
|
| Reconciled Depreciation |
|
0.02
-81.08%
|
0.11
-76.73%
|
0.48
|
| EBIT |
|
-0.82
+79.15%
|
-3.92
+94.28%
|
-68.48
|
| Net Income |
|
7.33
-82.94%
|
42.94
+162.86%
|
-68.31
|
| Pretax Income |
|
9.44
-2.01%
|
9.64
+114.11%
|
-68.31
|
| Other Income Expense |
|
10.26
-24.31%
|
13.56
+7874.71%
|
0.17
|
| Other Non Operating Income Expenses |
|
10.26
-24.31%
|
13.56
+7874.71%
|
0.17
|
| Tax Provision |
|
2.12
+106.36%
|
-33.30
|
0.00
|
| Tax Rate For Calcs |
|
0.00
+6.85%
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
7.33
-82.94%
|
42.94
+162.86%
|
-68.31
|
| Net Income From Continuing Operation Net Minority Interest |
|
7.33
-82.94%
|
42.94
+162.86%
|
-68.31
|
| Net Income From Continuing And Discontinued Operation |
|
7.33
-82.94%
|
42.94
+162.86%
|
-68.31
|
| Net Income Continuous Operations |
|
7.33
-82.94%
|
42.94
+162.86%
|
-68.31
|
| Normalized Income |
|
7.33
-82.94%
|
42.94
+162.86%
|
-68.31
|
| Net Income Common Stockholders |
|
7.33
-82.94%
|
42.94
+162.86%
|
-68.31
|
| Diluted EPS |
|
—
|
—
|
-142,027.03
|
| Basic EPS |
|
—
|
—
|
-142,027.03
|
| Basic Average Shares |
|
—
|
—
|
0.00
|
| Diluted Average Shares |
|
—
|
—
|
0.00
|
| Diluted NI Availto Com Stockholders |
|
7.33
-82.94%
|
42.94
+162.86%
|
-68.31
|
| Line Item | Trend | 2023-12-31 | 2021-12-31 |
|---|---|---|---|
| Total Assets |
|
110.45
+39.82%
|
79.00
|
| Current Assets |
|
57.09
-24.03%
|
75.15
|
| Cash Cash Equivalents And Short Term Investments |
|
57.02
-17.23%
|
68.89
|
| Cash And Cash Equivalents |
|
39.54
-42.60%
|
68.89
|
| Other Short Term Investments |
|
17.48
|
0.00
|
| Other Current Assets |
|
0.07
-98.91%
|
6.25
|
| Total Non Current Assets |
|
53.37
+1286.85%
|
3.85
|
| Net PPE |
|
0.39
-87.97%
|
3.21
|
| Gross PPE |
|
0.39
-87.97%
|
3.21
|
| Other Properties |
|
0.39
-87.97%
|
3.21
|
| Investments And Advances |
|
21.00
|
0.00
|
| Other Investments |
|
21.00
|
0.00
|
| Non Current Deferred Assets |
|
31.41
|
0.00
|
| Non Current Deferred Taxes Assets |
|
31.41
|
0.00
|
| Other Non Current Assets |
|
0.57
-11.09%
|
0.64
|
| Total Liabilities Net Minority Interest |
|
2.33
-88.18%
|
19.73
|
| Current Liabilities |
|
0.51
-96.77%
|
15.83
|
| Payables And Accrued Expenses |
|
0.01
-99.95%
|
15.06
|
| Payables |
|
0.00
-99.32%
|
0.29
|
| Accounts Payable |
|
0.00
-99.32%
|
0.29
|
| Current Accrued Expenses |
|
0.01
-99.97%
|
14.77
|
| Current Debt And Capital Lease Obligation |
|
0.50
-34.03%
|
0.76
|
| Current Capital Lease Obligation |
|
0.50
-34.03%
|
0.76
|
| Total Non Current Liabilities Net Minority Interest |
|
1.82
-53.34%
|
3.90
|
| Long Term Debt And Capital Lease Obligation |
|
1.79
-54.01%
|
3.90
|
| Long Term Capital Lease Obligation |
|
1.79
-54.01%
|
3.90
|
| Other Non Current Liabilities |
|
0.03
|
—
|
| Stockholders Equity |
|
108.12
+82.44%
|
59.26
|
| Common Stock Equity |
|
108.12
+82.44%
|
59.26
|
| Capital Stock |
|
0.00
-99.65%
|
0.29
|
| Common Stock |
|
0.00
-99.65%
|
0.29
|
| Share Issued |
|
0.00
-25.99%
|
0.00
|
| Ordinary Shares Number |
|
0.00
-25.99%
|
0.00
|
| Additional Paid In Capital |
|
492.37
-0.27%
|
493.72
|
| Retained Earnings |
|
-384.48
+11.56%
|
-434.74
|
| Gains Losses Not Affecting Retained Earnings |
|
0.23
|
0.00
|
| Other Equity Adjustments |
|
0.23
|
—
|
| Total Equity Gross Minority Interest |
|
108.12
+82.44%
|
59.26
|
| Total Capitalization |
|
108.12
+82.44%
|
59.26
|
| Working Capital |
|
56.58
-4.62%
|
59.32
|
| Invested Capital |
|
108.12
+82.44%
|
59.26
|
| Total Debt |
|
2.30
-50.74%
|
4.67
|
| Capital Lease Obligations |
|
2.30
-50.74%
|
4.67
|
| Net Tangible Assets |
|
108.12
+82.44%
|
59.26
|
| Tangible Book Value |
|
108.12
+82.44%
|
59.26
|
| Line Item | Trend | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow |
|
8.74
+386.91%
|
1.79
+102.37%
|
-75.72
|
| Cash Flow From Continuing Operating Activities |
|
8.74
+386.91%
|
1.79
+102.37%
|
-75.72
|
| Net Income From Continuing Operations |
|
7.33
-82.94%
|
42.94
+162.86%
|
-68.31
|
| Depreciation Amortization Depletion |
|
0.02
-81.08%
|
0.11
-76.73%
|
0.48
|
| Depreciation And Amortization |
|
0.02
-81.08%
|
0.11
-76.73%
|
0.48
|
| Other Non Cash Items |
|
0.07
-68.83%
|
0.23
-59.76%
|
0.57
|
| Stock Based Compensation |
|
0.00
-100.00%
|
0.18
-95.65%
|
4.18
|
| Asset Impairment Charge |
|
0.00
-100.00%
|
1.00
-48.80%
|
1.96
|
| Deferred Tax |
|
1.90
+105.71%
|
-33.31
|
0.00
|
| Deferred Income Tax |
|
1.90
+105.71%
|
-33.31
|
0.00
|
| Operating Gains Losses |
|
0.03
|
—
|
0.11
|
| Gain Loss On Sale Of PPE |
|
0.03
|
0.00
-100.00%
|
0.11
|
| Change In Working Capital |
|
-0.61
+93.52%
|
-9.36
+36.41%
|
-14.71
|
| Change In Prepaid Assets |
|
-0.06
-100.89%
|
6.18
+328.65%
|
-2.71
|
| Change In Payables And Accrued Expense |
|
-0.11
+99.28%
|
-14.95
-31.70%
|
-11.35
|
| Change In Accrued Expense |
|
-0.09
+99.41%
|
-14.68
-681.81%
|
2.52
|
| Change In Payable |
|
-0.02
+91.85%
|
-0.27
+98.05%
|
-13.87
|
| Change In Account Payable |
|
-0.02
+91.85%
|
-0.27
+98.05%
|
-13.87
|
| Change In Other Current Liabilities |
|
-0.44
+25.42%
|
-0.59
+9.86%
|
-0.66
|
| Investing Cash Flow |
|
20.15
+134.54%
|
-58.34
-224303.85%
|
-0.03
|
| Cash Flow From Continuing Investing Activities |
|
20.15
+134.54%
|
-58.34
-224303.85%
|
-0.03
|
| Net PPE Purchase And Sale |
|
0.00
-100.00%
|
0.05
+307.69%
|
-0.03
|
| Purchase Of PPE |
|
—
|
0.00
+100.00%
|
-0.03
|
| Sale Of PPE |
|
0.00
-100.00%
|
0.05
|
0.00
|
| Capital Expenditure |
|
—
|
—
|
-0.03
|
| Net Investment Purchase And Sale |
|
20.15
+134.50%
|
-58.40
|
0.00
|
| Purchase Of Investment |
|
-17.25
+70.46%
|
-58.40
|
0.00
|
| Sale Of Investment |
|
37.40
|
0.00
|
—
|
| Financing Cash Flow |
|
-0.20
+87.90%
|
-1.62
+87.29%
|
-12.75
|
| Cash Flow From Continuing Financing Activities |
|
-0.20
+87.90%
|
-1.62
+87.29%
|
-12.75
|
| Net Common Stock Issuance |
|
-0.20
+87.90%
|
-1.62
+88.07%
|
-13.57
|
| Common Stock Payments |
|
-0.20
+87.90%
|
-1.62
+88.07%
|
-13.57
|
| Repurchase Of Capital Stock |
|
-0.20
+87.90%
|
-1.62
+88.07%
|
-13.57
|
| Proceeds From Stock Option Exercised |
|
—
|
0.00
-100.00%
|
0.82
|
| Changes In Cash |
|
28.69
+149.33%
|
-58.17
+34.27%
|
-88.50
|
| Beginning Cash Position |
|
11.31
-83.72%
|
69.48
-56.02%
|
157.98
|
| End Cash Position |
|
40.00
+253.75%
|
11.31
-83.72%
|
69.48
|
| Free Cash Flow |
|
8.74
+386.91%
|
1.79
+102.37%
|
-75.75
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|